Abstract: A communications circuit includes a first circuit block and a second circuit block. The first circuit block includes a first splitter, a first signal path coupled to a first output of the first splitter, a second signal path coupled to a second output of the first splitter, and a first switch configured to couple the second signal path to a third signal path or to couple a fourth signal path to the third signal path. The second circuit block includes a second splitter, a fifth signal path coupled to a first output of the second splitter, a sixth signal path coupled to a second output of the second splitter, and a second switch configured to couple the sixth signal path to the third signal path or to couple a seventh signal path to the third signal path. The third signal path extends between the first and second circuit blocks.

Abstract: A programmable radio frequency (RF) memory system includes a receiver designed to receive an RF pulse, a memory, a waveform transform module, and a transmitter. The memory stores a digitized version of the RF pulse. The waveform transform module is designed to determine one or more characteristics of the digitized version of the RF pulse, and based on the determined one or more characteristics, transform the digitized version of the RF pulse into a transformed signal. The transformed signal has at least one characteristic that is different than the one or more characteristics. The transmitter is designed to transmit an analog equivalent of the transformed signal. The analog equivalent of the transformed signal and the received RF pulse are coherent.

Abstract: The present invention relates to the use of G-CSF and derivatives thereof for extending the therapeutic window of subsequent thrombolytic treatment of acute stroke, and thereby, allowing the diagnostic examinations which are necessary prior to the thrombolytic treatment in order to avoid hemorrhagic and other severe adverse side effects of the thrombolysis.

Abstract: The invention concerns laser decontamination of the surface of a shaped component (3). Said decontamination comprises the following steps: successively impinging parts of the surface of the shaped component (3) with pulsed laser beams of wavelengths in the ultraviolet range and enabling the surface layer of the shaped component (3) to be ablated in the form of particles, the laser beams being distributed so as to cover simultaneously each treated part; and recuperating by suction said particles.

Abstract: The invention is directed to a method of reducing the extent of infarction, particularly cerebral infarction subsequent to cerebral ischemia, by the administration of citicoline shortly after an ischemic episode and continuing daily treatment for up to about 30 days, preferably for at least about 6 weeks. The method is useful in the treatment of stroke and severe head trauma patients and maximizes the chances for a full or substantially full recovery of the patient.

Abstract: The invention is directed to a method of reducing the extent of infarction, particularly cerebral infarction subsequent to cerebral ischemia, by the administration of citicoline shortly after an ischemic episode and continuing daily treatment for up to about 30 days, preferably for at least about 6 weeks. The method is useful in the treatment of stroke and severe head trauma patients and maximizes the chances for a full or substantially full recovery of the patient. Combination treatment regimens are also disclosed along with compositions for use therewith.

Abstract: Methods and pharmaceutical compositions for reducing the extent of infarction, particularly cerebral infarction subsequent to cerebral ischemia.